Bone Morphogenetic Protein-7 Inhibits EMT-Associated Genes in Breast Cancer
Author(s) -
Ying Xue-xiang,
Yunpo Sun,
Pingqing He
Publication year - 2015
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000430249
Subject(s) - bone morphogenetic protein 7 , cancer research , carcinogenesis , transforming growth factor , bone morphogenetic protein , breast cancer , epithelial–mesenchymal transition , cancer , cell migration , metastasis , bone metastasis , endoglin , cell growth , biology , cell , medicine , endocrinology , microbiology and biotechnology , stem cell , gene , biochemistry , cd34
Bone morphogenetic protein-7 (BMP7) has been shown to reduce the severity of injury-induced fibrosis through counteracting the fibrotic effects of transforming growth factor β 1 (TGFβ1). However, this model in the carcinogenesis of breast cancer is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom